Search results
Results from the WOW.Com Content Network
Management of SIADH includes: [5] Treating the underlying cause when possible. Mild and asymptomatic hyponatremia is treated with adequate solute intake (including salt and protein) and fluid restriction with fluids (from all sources) restricted to 1–1.5 liters of fluid per day.
Cyclophosphamide (CP), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. [4]
An affiliate of AMDA – Dedicated to Long Term Care Medicine, [Notes 1] the American Medical Directors Certification Program (AMDCP) accredits Certified Medical Directors (CMD) in long-term care. The AMDCP's mission is “to recognize and advance physician leadership and excellence in medical direction throughout the long-term care continuum ...
The term "cerebral hyponatremia" was suggested in the work of Epstein, et al. 1961. Inappropriate release of endogenous vasopressin is probably responsible for hyponatremia in tuberculous meningitis. Inability to excrete water normally is also a feature of the salt wasting of certain hyponatremic patients with pulmonary tuberculosis.
Many people who have had a pituitary apoplexy develop pituitary hormone deficiencies and require long-term hormone supplementation. The first case of the disease was recorded in 1898. The first case of the disease was recorded in 1898.
Hormone replacement therapy began in the 1960s but gained traction in the late 1990s. [5] Therapy methods have been developed rapidly since the 1970s, and survivorship of individuals with hormone receptor-positive cancer has skyrocketed. [6]
If you'd instead put your $10,000 into an S&P 500 (SNPINDEX: ^GSPC) index fund, you would've had just $11,900 at the end of the year. An equal investment in an S&P 500 index fund would be worth ...
It was previously used in the treatment of breast cancer, but has been replaced by more effective and less toxic agents. Estrace is an estrogen which was also formerly used for antiandrogen therapy of prostate cancer. [2] Polyestradiol phosphate is a long-acting derivative of estradiol that is applied as an intramuscular injection.